Abstract | BACKGROUND: Excessive melanin production and accumulation are characteristics of a large number of skin diseases, including melasma, and post-inflammatory hyperpigmentation. During our on-going search for new agents with an inhibitory effect on tyrosinase, we synthesized a new type of tyrosinase inhibitor, 4-(thiazolidin-2-yl)benzene-1,2-diol (MHY-794), which directly inhibits mushroom tyrosinase. METHODS: The inhibitory effect of MHY-794 on tyrosinase activity and nitric oxide (NO) scavenging activity was evaluated in cell free system. Additional experiments were performed using B16F10 melanoma cells to demonstrate the effects of MHY-794 in vitro. HRM2 hairless mice were used to evaluate anti-melanogenic effects of MHY-794 in vivo. RESULTS: MHY-794 effectively inhibited mushroom tyrosinase activity in cell free system. In silico docking simulation also supported the inhibitory effects of MHY-794 on mushroom tyrosinase. MHY-794 also proved to be effective at scavenging nitric oxide (NO), which serves as an important modulator in the melanogenesis signaling pathway. In addition, MHY-794 effectively inhibited SNP (NO donor)-induced melanogenesis by directly inhibiting tyrosinase and diminishing NO-mediated melanogenesis signaling in B16 melanoma cells. The anti-melanogenic effects of MHY-794 were further confirmed in HRM2 hairless mice. Ultraviolet light (UV) significantly up-regulated NO-mediated melanogenesis signaling in HRM2 hairless mice, but MHY-794 effectively inhibited both melanogenesis and diminished UV-induced NO-signaling. CONCLUSIONS: Our results indicate that MHY-794 is highly effective at inhibiting NO-mediated melanogenesis in vitro and in vivo by direct NO scavenging and directly inhibiting tyrosinase activity, and suggest that MHY-794 be considered a new developmental candidate for the treatment of hyper- pigmentation disorders. GENERAL SIGNIFICANCE: MHY-794, which showed great efficacy on NO-mediated melanogenesis by direct NO scavenging as well as direct inhibition of tyrosinase catalytic activity, might be utilized for the development of a new candidate for treatment of the hyper- pigmentation disorders.
|
Authors | Ki Wung Chung, Hyoung Oh Jeong, Eun Ji Jang, Yeon Ja Choi, Dae Hyun Kim, So Ra Kim, Kyung Jin Lee, Hye Jin Lee, Pusoon Chun, Youngjoo Byun, Hyung Ryong Moon, Hae Young Chung |
Journal | Biochimica et biophysica acta
(Biochim Biophys Acta)
Vol. 1830
Issue 10
Pg. 4752-61
(Oct 2013)
ISSN: 0006-3002 [Print] Netherlands |
PMID | 23769841
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Melanins
- Small Molecule Libraries
- Thiazolidines
- Nitric Oxide
- Monophenol Monooxygenase
|
Topics |
- Animals
- Cell Line, Tumor
- Drug Design
- Melanins
(biosynthesis)
- Melanoma, Experimental
(enzymology, metabolism, pathology)
- Mice
- Monophenol Monooxygenase
(metabolism)
- Nitric Oxide
(metabolism)
- Skin Pigmentation
(drug effects, radiation effects)
- Small Molecule Libraries
- Thiazolidines
(chemistry, pharmacology)
- Ultraviolet Rays
|